Unknown PHASE4 INTERVENTIONAL 2-arm NCT01841294

NK Activity Modulation Induced by Intravenous Lidocaine During Colorectal Laparoscopic Surgery

NK Activity Modulation by Intravenous Lidocaine During Laparoscopic Colorectal Surgery

Sponsor: Maisonneuve-Rosemont Hospital

Interventions Intravenous Lidocaine Normal saline infusion

Updated 5 times since 2017 Last updated: Apr 25, 2013 Started: Jan 31, 2012 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01841294, this PHASE4 trial focuses on Colorectal Cancer and remains ongoing. Sponsored by Maisonneuve-Rosemont Hospital, it has been updated 5 times since 2012, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jan 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maisonneuve-Rosemont Hospital

Data source: Maisonneuve-Rosemont Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Montreal, Canada